DE963270C - Verfahren zur Herstellung von Tabletten - Google Patents
Verfahren zur Herstellung von TablettenInfo
- Publication number
- DE963270C DE963270C DEM25834A DEM0025834A DE963270C DE 963270 C DE963270 C DE 963270C DE M25834 A DEM25834 A DE M25834A DE M0025834 A DEM0025834 A DE M0025834A DE 963270 C DE963270 C DE 963270C
- Authority
- DE
- Germany
- Prior art keywords
- mesh size
- tablets
- glycine
- sieve
- pass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 26
- 239000004471 Glycine Substances 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 12
- 229960003893 phenacetin Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 4
- 229960001138 acetylsalicylic acid Drugs 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960000581 salicylamide Drugs 0.000 description 4
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229960004126 codeine Drugs 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 240000000991 Eucalyptus amygdalina Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB264154A GB749285A (en) | 1954-01-28 | 1954-01-28 | Improvements in or relating to the manufacture of tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE963270C true DE963270C (de) | 1957-05-02 |
Family
ID=9743153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEM25834A Expired DE963270C (de) | 1954-01-28 | 1955-01-20 | Verfahren zur Herstellung von Tabletten |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE534529A (esLanguage) |
| DE (1) | DE963270C (esLanguage) |
| GB (1) | GB749285A (esLanguage) |
| NL (2) | NL94807C (esLanguage) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4444052A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
| DE4444051A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
| JP2001278812A (ja) * | 2000-03-27 | 2001-10-10 | Kyoto Pharmaceutical Industries Ltd | 錠剤用崩壊剤及びこれを用いた錠剤 |
-
0
- NL NL193684D patent/NL193684A/xx unknown
- BE BE534529D patent/BE534529A/xx unknown
- NL NL94807D patent/NL94807C/xx active
-
1954
- 1954-01-28 GB GB264154A patent/GB749285A/en not_active Expired
-
1955
- 1955-01-20 DE DEM25834A patent/DE963270C/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB749285A (en) | 1956-05-23 |
| NL94807C (esLanguage) | |
| NL193684A (esLanguage) | |
| BE534529A (esLanguage) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60006376T2 (de) | Nikotinhaltige verabreichungssysteme | |
| DE68916731T2 (de) | Morphin enthaltende Zusammensetzung. | |
| DE69110592T2 (de) | Pharmazeutische Zubereitung mit verbessertem Geschmack, poröse Partikel enthaltend, und deren Herstellungsmethode. | |
| DE69218557T2 (de) | Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2414868A1 (de) | Arzneimittel und verfahren zu seiner herstellung | |
| CH639845A5 (en) | Solid depot pharmaceutical preparations and process for their production | |
| CH622947A5 (en) | Process for the production of a pharmaceutical composition which is in solid form and contains bismuth | |
| DE68903988T2 (de) | Acetylcystein enthaltende mundloesliche arzneimittel. | |
| DE2706660A1 (de) | Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung | |
| DE2951077C2 (esLanguage) | ||
| DE1767017C3 (de) | Steckkapsel-Eisenpräparat | |
| DE60306747T2 (de) | Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
| DE1617499B2 (de) | Zahnpaste | |
| DE2020893A1 (de) | Brausezubereitung und Verfahren zu ihrer Herstellung | |
| DE963270C (de) | Verfahren zur Herstellung von Tabletten | |
| DE3105813A1 (de) | "acesulfamhaltige zusammensetzung, tabletten auf basis dieser zusammensetzung und verfahren zu ihrer herstellung" | |
| DE2062715C3 (de) | Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung | |
| DE2514982A1 (de) | Tabletten und verfahren zu ihrer herstellung | |
| DE2115116A1 (de) | Verbesserte Gleitmittel und Ver fahren zur Herstellung derselben | |
| DE69524226T2 (de) | Verfahren zum herstellen von fusidinsäuretabletten | |
| DE475114C (de) | Verfahren zur Herstellung eines Zahnputzmittels | |
| DD202017A5 (de) | Verfahren zur herstellung von calciumoxaprozin | |
| DE1617638A1 (de) | Tablettenbindemittel | |
| DEM0025834MA (esLanguage) | ||
| DE69103724T2 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. |